Mr Sutton is a core member of the Advanced Pelvic Malignancy, Peritoneal Tumour Service and Neuroendocrine MDTs at The Christie. He specialises in the management of colorectal cancer, performing open and minimally invasive surgery for primary, advanced and recurrent cancer, including pelvic exenteration and sacrectomy. Mr Sutton also performs cytoreductive surgery with heated intra-peritoneal chemotherapy (HIPEC) for appendix tumours and colorectal peritoneal metastases, and surgery for neuroendocrine tumours. He is a JAG accredited endoscopist and performs diagnostic and therapeutic colonoscopy.

Mr Sutton’s research interests are in predicting and modifying response to adjuvant therapy in colorectal cancer, and more recently in improving outcomes for patients with locally advanced and recurrent rectal cancer. He has published over 80 peer-reviewed papers and is an editor for The BJS (formerly The British Journal of Surgery). Mr Sutton is an Honorary Senior Lecturer in the Division of Cancer Sciences at The University of Manchester undertaking clinical, quality of life and genomic research into locally recurrent rectal cancer.